Results 131 to 140 of about 70,987 (344)
Infiltrating Bladder Urothelial Carcinoma, Lymphoma-Like Variant
, 2020 National Cancer Institute
openalex +1 more source
TP53 mutational analysis supports monoclonal origin of biphasic sarcomatoid urothelial carcinoma (carcinosarcoma) of the urinary bladder [PDF]
, 2008 Andrew Armstrong +10 more
openalex +1 more source
Supplementary Figure Legend from Novel Tumor Subgroups of Urothelial Carcinoma of the Bladder Defined by Integrated Genomic Analysis [PDF]
, 2023 Carolyn D. Hurst +3 more
openalex +1 more source
Intravesical therapy for urothelial carcinoma of the bladder
Indian Journal of Urology, 2011 Transurethral resection is an effective therapy for non-muscle-invasive bladder cancer. However, the high rates of recurrence and significant risk of progression in higher grade tumors mandates additional therapy with intravesical agents. In this review we discuss the role of various intravesical agents currently in use including the immunomodualtory ...
openaire +3 more sources
Bladder: Urothelial carcinomas [PDF]
Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2011 AA van Tilborg, Rhijn BW van
openaire +1 more source
Long‐term outcomes following a 5‐year recurrence‐free interval in non‐muscle‐invasive bladder cancer
BJU International, EarlyView.Objective To describe the recurrence and progression trends of non‐muscle‐invasive bladder cancer (NMIBC) during a 14‐year period in Denmark between 2009 and 2022. Furthermore, to evaluate the risk of late recurrence with or without progression in patients who initially experience a 5‐year recurrence‐free interval (RFI).
Peter B. Hjort +2 more
wiley +1 more source
Grading Systems for Canine Urothelial Carcinoma of the Bladder: A Comparative Overview [PDF]
, 2022 Eleonora Brambilla +5 more
openalex +1 more source
BJU International, EarlyView.Objectives To evaluate whether a simplified risk model preserves the prognostic performance of the International Bladder Cancer Group (IBCG) five‐factor risk stratification model in intermediate‐risk (IR) non‐muscle‐invasive bladder cancer (NMIBC). Patients and Methods We performed a multicentre retrospective analysis of 2822 patients with IR NMIBC ...
Jayant Siva +12 more
wiley +1 more source
Urothelial Carcinoma Clear Cell Variant of the Urinary Bladder : A Case Report [PDF]
, 2010 A 69-year-old woman who had been treated with hemodialysis for 16 months for chronic renal failure presented with a chief complaint of gross hematuria in March 2007.
佐藤, 全伯 +8 more
core